PATENT CLAIM ANALYSIS

Application Number: 16126791
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2018-12
Patent Classification: ["424", "204100"]

Abstract:
The present invention relates, in general, to attenuated swine influenza viruses having an impaired ability to antagonize the cellular interferon (IFN) response, and the use of such attenuated viruses in vaccine and pharmaceutical formulations. In particular the invention relates to attenuated swine influenza viruses having modifications to a swine NS1 gene that diminish or eliminate the ability of the NS1 gene product to antagonize the cellular IFN response. These viruses replicate in vivo, but demonstrate decreased replication, virulence and increased attenuation, and therefore are well suited for use in live virus vaccines, and pharmaceutical formulations.

Claim (Index 63):
The cell of  claim 58 , wherein the attenuated swine influenza virus has a segmented genome comprising at least one segment derived from a different virus.

Metadata:
- Claim Count in Document: 89.0
- Percentile: 97.0
- Lexical Diversity: 1.7541
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14636651', '13304175', '15375664', '11628292', '11884401']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8538910767626301
- 35 USC 102 Novelty (BERT): 0.6937591340121456
- Combined Prediction Score: 0.8378778824875817
- Mean Citation Score: 799.7102940000003
- Max Citation Score: 974.8626
- Similarity Product: 682.451629895711

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test